Rxsight Stock Retained Earnings

RXST Stock  USD 26.50  0.66  2.55%   
Rxsight fundamentals help investors to digest information that contributes to Rxsight's financial success or failures. It also enables traders to predict the movement of Rxsight Stock. The fundamental analysis module provides a way to measure Rxsight's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rxsight stock.
Last ReportedProjected for Next Year
Retained Earnings-622.1 M-653.2 M
Retained Earnings Total Equity-491.4 M-516 M
Retained Earnings is likely to drop to about (653.2 M) in 2025. Retained Earnings Total Equity is likely to drop to about (516 M) in 2025.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Rxsight Company Retained Earnings Analysis

Rxsight's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

Retained Earnings

 = 

Beginning RE + Income

-

Dividends

More About Retained Earnings | All Equity Analysis

Current Rxsight Retained Earnings

    
  (622.1 M)  
Most of Rxsight's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rxsight is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Rxsight Retained Earnings Driver Correlations

Understanding the fundamental principles of building solid financial models for Rxsight is extremely important. It helps to project a fair market value of Rxsight Stock properly, considering its historical fundamentals such as Retained Earnings. Since Rxsight's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Rxsight's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Rxsight's interrelated accounts and indicators.
0.870.820.850.02-0.830.790.851.0-0.820.861.0-0.811.00.21-0.81-0.850.89-0.610.9
0.870.980.90.23-0.950.670.910.85-0.981.00.89-0.960.880.46-0.96-0.970.98-0.670.77
0.820.980.80.36-0.90.60.820.79-1.00.990.84-0.980.830.62-0.98-0.990.99-0.530.65
0.850.90.8-0.08-0.980.81.00.82-0.830.880.85-0.790.830.1-0.79-0.810.81-0.850.92
0.020.230.36-0.08-0.07-0.35-0.06-0.01-0.330.280.04-0.260.030.87-0.26-0.360.340.2-0.14
-0.83-0.95-0.9-0.98-0.07-0.76-0.98-0.790.92-0.94-0.840.88-0.82-0.290.880.9-0.880.76-0.84
0.790.670.60.8-0.35-0.760.790.79-0.630.640.79-0.670.78-0.03-0.67-0.660.64-0.480.8
0.850.910.821.0-0.06-0.980.790.82-0.840.890.86-0.80.840.12-0.8-0.830.82-0.830.91
1.00.850.790.82-0.01-0.790.790.82-0.790.840.99-0.791.00.18-0.79-0.820.87-0.590.88
-0.82-0.98-1.0-0.83-0.330.92-0.63-0.84-0.79-0.99-0.840.97-0.83-0.590.970.99-0.980.54-0.67
0.861.00.990.880.28-0.940.640.890.84-0.990.88-0.960.870.5-0.96-0.980.98-0.640.75
1.00.890.840.850.04-0.840.790.860.99-0.840.88-0.821.00.24-0.82-0.870.9-0.60.89
-0.81-0.96-0.98-0.79-0.260.88-0.67-0.8-0.790.97-0.96-0.82-0.82-0.591.00.96-0.960.52-0.64
1.00.880.830.830.03-0.820.780.841.0-0.830.871.0-0.820.23-0.82-0.850.9-0.590.88
0.210.460.620.10.87-0.29-0.030.120.18-0.590.50.24-0.590.23-0.59-0.610.580.18-0.05
-0.81-0.96-0.98-0.79-0.260.88-0.67-0.8-0.790.97-0.96-0.821.0-0.82-0.590.96-0.960.52-0.64
-0.85-0.97-0.99-0.81-0.360.9-0.66-0.83-0.820.99-0.98-0.870.96-0.85-0.610.96-0.990.48-0.69
0.890.980.990.810.34-0.880.640.820.87-0.980.980.9-0.960.90.58-0.96-0.99-0.520.71
-0.61-0.67-0.53-0.850.20.76-0.48-0.83-0.590.54-0.64-0.60.52-0.590.180.520.48-0.52-0.82
0.90.770.650.92-0.14-0.840.80.910.88-0.670.750.89-0.640.88-0.05-0.64-0.690.71-0.82
Click cells to compare fundamentals
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
Competition

Based on the latest financial disclosure, Rxsight has a Retained Earnings of (622.1 Million). This is 166.79% lower than that of the Health Care Equipment & Supplies sector and 183.12% lower than that of the Health Care industry. The retained earnings for all United States stocks is 106.67% higher than that of the company.

Rxsight Retained Earnings Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rxsight's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Rxsight could also be used in its relative valuation, which is a method of valuing Rxsight by comparing valuation metrics of similar companies.
100%
Rxsight is currently under evaluation in retained earnings category among its peers.

Rxsight ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Rxsight's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Rxsight's managers, analysts, and investors.
53.0%
Environmental
57.1%
Governance
56.2%
Social

Rxsight Fundamentals

Return On Equity-0.12
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-50%0%50%
Return On Asset-0.0919
Profit Margin(0.20) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Operating Margin(0.21) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Current Valuation820.74 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%250%300%
Shares Outstanding40.49 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%10%20%30%40%
Shares Owned By Insiders5.05 %
Shares Owned By Institutions91.19 %
Number Of Shares Shorted2.41 M
Price To Earning42.55 X
Price To Book3.72 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-700%-600%-500%-400%-300%-200%-100%0%
Price To Sales7.48 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Revenue139.93 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%5,000%6,000%
Gross Profit98.94 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-5,000%-4,000%-3,000%-2,000%-1,000%
EBITDA(23.76 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-150%-100%-50%0%50%
Net Income(27.45 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-150%-100%-50%
Cash And Equivalents128.62 M
Cash Per Share4.65 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-20%0%20%40%60%80%100%
Total Debt12.3 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%100%200%300%400%500%600%700%
Debt To Equity0.41 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-2,500%-2,000%-1,500%-1,000%-500%0%500%
Current Ratio11.54 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-20%0%20%40%
Book Value Per Share6.96 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-150%-100%-50%
Cash Flow From Operations(16.95 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-60%-40%-20%0%20%40%
Short Ratio4.62 X
Earnings Per Share(0.71) X
Price To Earnings To Growth0.03 X
Target Price44.8
Number Of Employees498
Beta1.22
Market Capitalization1.05 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%250%300%350%
Total Asset318.56 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%50%100%150%
Retained Earnings(622.1 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3110%20%30%40%50%
Working Capital267.95 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Net Asset318.56 M

About Rxsight Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Rxsight's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rxsight using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rxsight based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.